ALTO-300 in Depression (ALTO-300-004)
Condition(s):Major Depressive DisorderLast Updated:May 22, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Major Depressive DisorderLast Updated:May 22, 2023Completed
Condition(s):End Stage Renal Disease (ESRD); Kidney Failure; Chronic Renal DiseaseLast Updated:June 12, 2023Recruiting
Condition(s):Persistent Atrial FibrillationLast Updated:January 6, 2023Recruiting
Condition(s):Diabetes Mellitus, Type 2Last Updated:June 17, 2016Completed
Condition(s):Prosthesis User; AmputationLast Updated:April 6, 2020Completed
Condition(s):Pulmonary Embolism; Deep Vein Thrombosis; Venous ThromboembolismLast Updated:August 26, 2015Terminated
Condition(s):Cervical Cancer; Gastric Cancer; Stomach Cancer; Gastroesophageal Junction Cancer; Esophageal Cancer; Hepatocellular Carcinoma; Melanoma; Uveal Melanoma; Merkel Cell Carcinoma; Mesothelioma; MSI; Non-small Cell Lung Cancer; NSCLC; Ovarian Cancer; Squamous Cell Carcinoma of the Head and Neck; Small Cell Lung Cancer; Renal Cell Carcinoma; RCC; Triple-negative Breast Cancer; Urothelial Carcinoma; Mismatch Repair DeficiencyLast Updated:November 15, 2021Completed
Condition(s):Sickle Cell AnemiaLast Updated:June 25, 2021Completed
Condition(s):Major Depressive DisorderLast Updated:December 8, 2023Recruiting
Condition(s):Parkinson Disease; Movement DisordersLast Updated:February 5, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.